Drug Approval Icon Reverse RGB


Involved in 75% of all FDA approvals of oncology compounds since 2012

Employee Recruitment Icon Reverse RGB


1M+ enrolled patients

Site Icon Reverse RGB


Experience working with 160k+ sites worldwide

Team Icon Reverse RGB


Full time, on-staff medical and scientific experts dedicated to oncology trials

Your trusted partner in oncology trials

With 50+ years’ experience, Clario’s expertise spans all Phases (I-IV) of oncology trials, and is the partner of choice for top pharmaceutical companies, biotechs and CROs seeking to excel in oncology and solid tumor trials.

Our dedicated team of scientific experts and operational specialists brings unmatched experience and best practices from our long history of successful studies, making us an invaluable collaborator in your trial’s success.

Efficacy: Elevating Disease Progression Assessment

With nearly 2,000 imaging oncology studies, Clario brings proven response criteria expertise complemented by unmatched experience, ensuring you benefit from precision and superior operational processes in your trials.

Key highlights include:

Experience beyond measure

Our extensive involvement in successful solid tumor trials positions us as the unmatched leaders in the field.

Versatile solutions

Our adaptable reader platform and customizable modalities guarantee precise data collection across diverse cancer types and study designs.

Forward-thinking technology

Backed by a robust reader platform and cutting-edge solutions, we redefine the boundaries of clinical research.

Comprehensive imaging platforms

Clario provides software capabilities from automated image de-identification to image analysis platforms that are fully customizable to your study’s endpoints and objectives. Our platforms are centered around robust data capture methods that meet regulatory compliance standards.

Our approach enables you to maximize the potential of your trial’s efficacy assessment, fueling groundbreaking insights and driving the evolution of oncology research.

Learn more about Clario’s efficacy in oncology clinical trials.

Safety: Optimizing for Trial Safety Requirements

Clario’s commitment to patient safety is at the core of our oncology drug development support. With 2,300+ cardiac safety trials and involvement in 70+ novel oncology drug approvals in the past decade, we provide critical insights to sponsors by analyzing patient risk profiles and focusing on safety endpoints.

Our approach includes:

Tailored safety strategies

Our scientific experts collaborate with sponsors to create safety strategies suited to unique program requirements.

Precision analysis

Leveraging technologies like electrocardiogram (ECG), blood pressure, echocardiograms and respiratory assessments, we ensure a thorough understanding of treatment effects. Our centralized ECG solution enhances patient precision and expands patient pools by up to 45%*.

Global reach

We offer robust solutions for trials worldwide, having supported 473,000 oncology patients globally across 54,000 sites and more than 2,400 trials in all phases.

Safety isn’t just a consideration – it’s a cornerstone of our ethos, safeguarding patients and driving the success of your study. As a trusted name in cardiac safety, we use a centralized approach to data collection and offer regulatory consulting on strategic protocol and study design.

*Kleiman et al., 2015

Quality of Life (QoL): Enhancing Patient Well-being

At Clario, we understand that every trial is a journey for patients, and their quality of life is at the heart of our focus.

Our commitment to improving patients’ lives extends to:

Patient-centric approaches

Our electronic Clinical Outcome Assessment (eCOA) solutions empower patients to conveniently share their experiences, enhancing data quality and patient engagement.

Scientific support

In a dynamic regulatory landscape, our scientific expertise and extensive experience stand as differentiators, benefiting clients and trial outcomes alike.

Deeper insights

Through our Cogstate partnership, we use rapid and reliable digital cognitive assessments, along with ePROs, to gauge oncology drugs’ cognitive effects. This insight provides drug developers a competitive advantage, highlighting the therapy’s broader impact beyond tumor response.

Commitment to speed

Clario’s library of pre-built commonly used eCOA oncology assessments gets you from study design to software release in just 5 weeks.

Beyond survival rates, Clario prioritizes the impact of treatments on patients’ mental health and daily functionality, ensuring their well-being remains paramount.

Experience in oncology trials isn’t optional – it’s essential. Trust Clario.

Clario’s expertise in oncology clinical trials encompasses every critical facet – from efficacy and safety to quality of life. Our dedication to excellence is reflected in our comprehensive understanding of:

Protocol design

Crafting a robust study blueprint to ensure effective execution and accurate results.

Endpoint expertise

Clario’s scientists help select the best endpoint solutions for reliable, high-quality data.

Site management

Helping ensure seamless operations at every study location, regardless of scale or complexity.

Patient support

Providing comprehensive assistance to patients, enhancing their experience and ensuring optimal data collection.

Clario’s medical and scientific expertise is revolutionizing what’s possible.

From new trial methodologies to faster and integrated evidence and findings, our innovative oncology trial solutions ensure we deliver the regulatory compliant data you need.

Talk to a specialist

Our team of experts is available to address any questions you may have about our oncology solutions. Submit your contact information and we’ll be in touch shortly.

Oncology Science Team


Every study, irrespective of its size or complexity, receives the same dedicated attention from Clario, supported by our TA-specific scientists, superior project management and regulatory proficiency—all proven over 50 successful years.

Pride in our 50-year legacy of quality, on-time oncology data delivery fuels our partnership with you. We bring robust scientific acumen, advanced technology across Medical Imaging, Cardiac Safety, eCOA and Precision Motion, and efficient operational execution to deliver the robust, timely data you require.

From planning a clinical trial through endpoint collection to database lock, we partner with our customers every step of the way to generate the rich evidence needed to bring medicines, medical devices and other therapies to market. We do this by being an industry leader across multiple disciplines including:

  • Medical Imaging
  • Cardiac Safety
  • eCOA
  • Precision Motion

Absolutely. Think of Clario as your oncology trial’s ally, dynamically scaling and evolving with your trial/team. Our scientific and operational teams’ initial deep dive into your specific needs lays the groundwork for a flexible, adaptable partnership. Not to mention, we have 50+ years’ experience conducting all Phases (I, II, III, IV) of oncology trials; so regardless of the support needed – we will be there.

Clario’s wide-ranging experience and in-house medical expertise enable us to manage not only standard trials, but also specialize in developing and overseeing novel, complex studies.

Talk to a specialist

Our team of experts is available to address any questions you may have about our oncology solutions. Submit your contact information and we’ll be in touch shortly.